DCN and breast carcinoma: In a similar fashion, since the expression of decorin was reduced in the CM of EO cells compared to the CM of vehicle-treated osteoblasts (Fig. 8a), we treated breast cancer cells with EO CM plus recombinant decorin protein (Fig. 9d–f).